...
首页> 外文期刊>Cell biochemistry and biophysics >Hepatocellular Carcinoma in Budd-Chiari Syndrome: Enhancement Patterns at Dynamic Gadolinium-Enhanced T1-Weighted MR Imaging
【24h】

Hepatocellular Carcinoma in Budd-Chiari Syndrome: Enhancement Patterns at Dynamic Gadolinium-Enhanced T1-Weighted MR Imaging

机译:Budd-Chiari综合征的肝细胞癌:动态Dynamic增强T1加权MR成像的增强模式。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of this study was to analyze the enhancement patterns at dynamic gadolinium-enhanced T1-weighted MR imaging in patients of Hepatocellular Carcinoma (HCC) with associated Budd-Chiari syndrome (BCS). The MR imaging findings in 10 patients of HCC with associated BCS were compared to those of 32 other patients of HCC without BCS. During the arterial phase, significantly more lesions with BCS were hyperintense than lesions without BCS; during the equilibrium phase, significantly more lesions with BCS were slightly hyperintense or isointense than lesions without BCS (P < 0.05 for both). For HCC, contrast enhancement on MRI shows different enhancement patterns between patients of HCC with associated BCS and those without BCS.
机译:这项研究的目的是分析伴有Budd-Chiari综合征(BCS)的肝细胞癌(HCC)患者的动态g增强T1加权MR成像的增强模式。将10例伴有BCS的HCC患者与其他32例不伴BCS的HCC患者的MR影像学结果进行了比较。在动脉期,高强度的BCS病变比没有BCS的病变多。在平衡阶段,与没有BCS的病变相比,具有BCS的病变稍高强度或等强度的病变明显多(两者均P <0.05)。对于HCC,MRI对比增强显示伴有BCS的HCC患者和不伴BCS的HCC患者之间的增强方式不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号